Evaluation of Patient Experience With A Model of Coordinated Telematic Pharmaceutical Care Between Hospital and Rural Pharmacies in Spain: A Proof of Concept

References

• World Health Organization. WHO library. Telemedicine. opportunities and developments in members states. Ginebra (Suiza); 2010. Available from: www.who.int/goe/publications/goe_telemedicine_2010.pdf. Accessed May 28, 2020.
   Google Scholar
• European Patients Forum. Carta sobre el Empoderamiento de los Pacientes. Luxemburgo; 2020. Avialable from: https://www.eu-patient.eu/globalassets/campaign-patient-empowerment/charter/charter_es-final.pdf. Accessed May 28, 2020.
   Google Scholar
• Alexander E, Butler CD, Darr A, et al. ASHP Statement on Telepharmacy. Am J Health Syst Pharm. 2017;74(9):236–241. doi:10.2146/ajhp170039
   Google Scholar
• US National Association of Boards of Pharmacy. Telepharmacy: the new frontier of patient care and professional practice. Mount Prospect (Illinois, EEUU); 2017. Available from: https://nabp.pharmacy/wpontent/uploads/2016/07/Innovations_June_July_Final.pdf. Accessed May 27, 2020.
   Google Scholar
• Canadian Society of Hospital Pharmacist. Telepharmacy guidelines. Ottawa (Canadá); 2017. Avialable from: https://www.cshp.ca/sites/default/files/files/publications/Official%20Publications/Telepharmacy%20Guidelines_2018.pdf. Accessed May 28, 2020.
   Google Scholar
• Sociedad Española de Farmacia Hospitalaria [Spanish Society of Hospital Pharmacy]. Proyecto Mapex: marco Estratégico de Telefarmacia [MAPEX Project. Strategic Framework in Telepharmacy]. Madrid; 2020. Available from: https://www.sefh.es/mapex/index.php/documentacion. Accessed May 28, 2020. Spanish.
   Google Scholar
• Morillo-Verdugo R, Calleja-Hernandez MA, Robustillo-Cortes MLA. A new pharmaceutical care concept: more capable, motivated, and timely. Hosp Pharm. 2019;54:348–350. doi:10.1177/0018578719867657
   PubMed Web of Science ®Google Scholar
• Cantillana-Suárez MG, Robustillo-Cortés MLA, Gutiérrez-Pizarraya A, Morillo-Verdugo R. Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the capacity-motivation-opportunity pharmaceutical care model: the IRAFE study. Eur J Hosp Pharm. 2021;28:e157–e163. doi:10.1136/ejhpharm-2020-002330
   PubMedGoogle Scholar
• Guzmán Ramos MI, Manzano Garcia M, Robustillo-Cortés MA, Gutiérrez Pizarraya A, Morillo-Verdugo R. Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study. Rev Esp Quimioter. 2021;34:459–467. doi:10.37201/req/025.2021
   PubMed Web of Science ®Google Scholar
• Caso-González A, Núñez-Rodríguez J, González-Pérez Y, Leralta-González C, Sanz-Alonso V, Obaldia-Alaña C. Eficacia de una intervención farmacéutica basada en el modelo CMO sobre la adherencia a fármacos biológicos y la experiencia del paciente con enfermedad reumática (Estudio ADhER-2). [Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study)]. An Sist Sanit Navar. 2022;45(2):e1004. Spanish. doi:10.23938/ASSN.1004
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Vélez-Díaz-Pallarés M, Fernández-Pacheco García-Valdecasas M, Fernández-Espínola S, Sánchez-Rubio Ferrández J, Navarro-Ruiz A. Application of the CMO methodology to the improvement of primary adherence to concomitant medication in people living with-HIV. The PRICMO Project. Farm Hosp. 2021;45:247–252.
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Robustillo-Cortés MA, Manzano García M, Almeida-González CV. Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients. Rev Esp Quimioter. 2019;32:40–49. doi:10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Ibrahim OM, Ibrahim RM, Al Meslamani Z, Al Mazrouei N. Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. J Telemed Telecare. 2023;29(1):18–27. doi:10.1177/1357633X20964347
   PubMedGoogle Scholar
• Dat TV, Tu VL, Quan NK, et al. Telepharmacy: a systematic review of field application, benefits, limitations, and applicability during the COVID-19 pandemic. Telemed J E Health. 2022;29:209–221. doi:10.1089/tmj.2021.0575
   PubMed Web of Science ®Google Scholar
• Jirjees F, Odeh M, Aloum L, Kharaba Z, Alzoubi KH, Al-Obaidi HJ. The rise of telepharmacy services during the COVID-19 pandemic: a comprehensive assessment of services in the United Arab Emirates. Pharm Pract. 2022;20(2):2634. doi:10.18549/PharmPract.2022.2.2634
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Margusino-Framiñán L, Monte-Boquet E, et al. Spanish society of hospital pharmacy position statement on telepharmacy: recommendations for its implementation and development. Farm Hosp. 2020;44(4):174–181. English. doi:10.7399/fh.11515
   PubMed Web of Science ®Google Scholar
• Le T, Toscani M, Colaizzi J. Telepharmacy: a new paradigm for our profession. J Pharm Pract. 2020;33(2):176–182. doi:10.1177/0897190018791060
   PubMed Web of Science ®Google Scholar
• Baldoni S, Amenta F, Ricci G. Telepharmacy services: present status and future perspectives: a review. Medicina. 2019;55(7):327. doi:10.3390/medicina55070327
   PubMed Web of Science ®Google Scholar
• Mohamed Ibrahim O, Ibrahim RM, Abdel-Qader DH, Al Meslamani AZ, Al Mazrouei N. Evaluation of Telepharmacy Services in Light of COVID-19. Telemed J E Health. 2021;27(6):649–656. doi:10.1089/tmj.2020.0283
   PubMed Web of Science ®Google Scholar
• Al Meslamani AZ, Kassem AB, El-Bassiouny NA, Ibrahim OM. An emergency plan for management of COVID-19 patients in rural areas. Int J Clin Pract. 2021;75(10):e14563. doi:10.1111/ijcp.14563
   PubMedGoogle Scholar
• Al Mazrouei N, Ibrahim RM, Al Meslamani AZ, Abdel-Qader DH, Mohamed Ibrahim O. Virtual pharmacist interventions onabuse of over-the-counter medications during COVID-19 versus traditional pharmacist interventions. J Am Pharm Assoc. 2021;61(3):331–339. doi:10.1016/j.japh.2021.02.003
   Google Scholar
• Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Calleja-Hernández MÁ, Robustillo-Cortés MLA, Poveda-Andrés JL. A new definition and refocus of pharmaceutical care: the Barbate document. Farm Hosp. 2020;44(4):158–162. English. doi:10.7399/fh.11389
   PubMed Web of Science ®Google Scholar
• Mira JJ, Nuño-Solinís R, Guilabert-Mora M, et al. Development and validation of an instrument for assessing patient experience of chronic illness care. Int J Integr Care. 2016;16:13. doi:10.5334/ijic.2443
   PubMed Web of Science ®Google Scholar
• Monje-Agudo P, Borrego-Izquierdo Y, Robustillo-Cortés Mde L, Jiménez-Galán R, Almeida-González CV, Morillo-Verdugo RA. Diseño y validación de una encuesta de satisfacción con la atención farmacéutica recibida en las consultas de farmacia hospitalaria. [Design and validation of a satisfaction survey with pharmaceutical care received in hospital pharmacy consultation]. Farm Hosp. 2015;39:152–156. Spanish. doi:10.7399/fh.2015.39.3.8366
   PubMedGoogle Scholar
• Carle PD, Uema SA, Pérez SR, Pallarés MM, Uthurry NH, Dáder MJ. Validación de un cuestionario de satisfacción de pacientes con el servicio de dispensación en farmacias comunitarias [Validation of a questionnaire on patient satisfaction with the dispensing service in community pharmacies]. Aten Primaria. 2007;39(11):591–596. Spanish. doi:10.1157/13112195
   PubMedGoogle Scholar
• Morillo Verdugo R, Villarreal Arevalo AL, Alvarez DSM, Robustillo Cortes ML. Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model. Farm Hosp. 2016;40(n06):544–568. English. doi:10.7399/fh.2016.40.6.10567
   PubMedGoogle Scholar
• D Crosswalk Index Value Calculator. Available from https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/crosswalk-index-value-calculator/. Accessed November 28, 2022.
   Google Scholar
• Calderon-Larranaga A, Gimeno-Feliu LA, Gonzalez-Rubio F. Polypharmacy patterns: unravelling systematic associations between prescribed medications. PLoS One. 2013;8(12):e84967. doi:10.1371/journal.pone.0084967
   PubMed Web of Science ®Google Scholar
• Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One. 2012;7:e32190. doi:10.1371/journal.pone.0032190
   PubMed Web of Science ®Google Scholar
• Allan J, Webster E, Chambers B, Nott S. This is streets ahead of what we used to do”: staff perceptions of virtual clinical pharmacy services in rural and remote Australian hospitals. BMC Health Serv Res. 2021;21(1):1306. doi:10.1186/s12913-021-07328-w
   PubMed Web of Science ®Google Scholar
• Pathak S, Haynes M, Qato DM, Urick BY. Telepharmacy and quality of medication use in rural areas, 2013–2019. Prev Chronic Dis. 2020;17:E101. doi:10.5888/pcd17.200012
   PubMed Web of Science ®Google Scholar
• Inch J, Notman F, Watson M, et al., Telepharmacy Research Team. Tele-pharmacy in rural Scotland: a proof of concept study. Int J Pharm Pract. 2017;25(3):210–219. doi:10.1111/ijpp.12376
   PubMedGoogle Scholar
• Al Meslamani AZ, Aldulaymi R, El Sharu H, Alwarawrah Z, Ibrahim OM, Al Mazrouei N. The patterns and determinants of telemedicine use during the COVID-19 crisis: a nationwide study. J Am Pharm Assoc. 2022;62(6):1778–1785. doi:10.1016/j.japh.2022.05.020
   Google Scholar
• Morillo-Verdugo R, Lazaro-Lopez A, Alonso-Grandes E, et al. Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV. J Multidiscip Healthc. 2022;15:2991–3003. doi:10.2147/JMDH.S392398
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Collado-Borell R, Arrondo-Velasco A, et al. Implementation of pharmaceutical care through Telepharmacy: a guide for professionals and patients. Farm Hosp. 2022;46(7):115–122.
   PubMedGoogle Scholar
• Sanmartín-Fenollera P, Mangues-Bafalluy I, Talens-Bolos A, et al. Telepharmacy scorecard: activity and quality indicators for the pharmaceutical care in a hospital pharmacy service. Farm Hosp. 2022;46(7):92–105.
   PubMedGoogle Scholar
• Monte-Boquet E, Hermenegildo-Caudevilla M, Vicente-Escrig E, et al. The telepharmacy patient prioritisation model of the Spanish Society of Hospital Pharmacy. Farm Hosp. 2022;46(7):106–114.
   PubMedGoogle Scholar
• Morillo-Verdugo R, Robustillo-Cortes MLA, Navarro-Ruiz A, et al. Clinical impact of the capacity-motivation-opportunity pharmacist-led intervention in people living with HIV in Spain, 2019–2020. J Multidiscip Healthc. 2022;15:1203–1211. doi:10.2147/jmdh.S361305
   PubMed Web of Science ®Google Scholar